Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2006-07-17

Original market date: See footnote 1

1998-08-13

Product name:

MENOMUNE-A/C/Y/W-135

DIN:

02161184 Electronic product monograph is not available

Company:

AVENTIS PASTEUR LIMITED
1755 Steeles Avenue West
Toronto
Ontario
Canada M2R 3T4

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

4

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07AH04 MENINGOCOCCUS, A, C, Y, W-135, TETRAVAL. PURIFIED POLYSACC. ANTIGEN

Active ingredient group (AIG) number:See footnote5

0440084003

List of active ingredient(s)
Active ingredient(s) Strength
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A 2.5 MG / KIT
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C 2.5 MG / KIT
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135 2.5 MG / KIT
MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y 2.5 MG / KIT
Version 4.0.2
Date modified: